← Open Payments lookup

DEBRA SCHULTZ: Open Payments

NPI 1124194279 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$490 in 24 payments from 11 companies in 2025. Trend: 2023 $193 · 2024 $406 · 2025 $490

Food & beverage: $490
CompanyPaymentsAmount
GlaxoSmithKline, LLC.10$152
AstraZeneca Pharmaceuticals LP4$96
Viatris Specialty LLC2$51
Actelion Pharmaceuticals US, Inc.1$32
Boehringer Ingelheim Pharmaceuticals, Inc.1$29
Regeneron Healthcare Solutions, Inc.1$27
INOGEN, INC.1$27
Takeda Pharmaceuticals U.S.A., Inc.1$23
Electromed, Inc.1$20
Insmed, Inc.1$20

Products named: TRELEGY ELLIPTA, NUCALA, FASENRA, YUPELRI, OPSUMIT, JASCAYD, DUPIXENT, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH.

Industry payments across MI — which companies pay providers there.